Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy-Reference-Cited by-同舟云学术

Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy

Published:2020-02 Issue: Volume:211 Page:108321
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Grunebaum Eyal,Reid Brenda,Naqvi Ahmed,Hershfield Michael S.,Kim Vy Hong-Diep,Muller Matthew P.,Hicks Lisa K.,Lee Erika,Betschel Stephen,Roifman Chaim M.

Funder

Donald and Audrey Campbell

Hospital for Sick Children

University of Toronto

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies;Grunebaum;Curr. Opin. Allergy Clin. Immunol.,2013

2. Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients;Sauer;Sci. Rep.,2017

3. Characteristic scapular and rib changes on chest radiographs of children with ADA-deficiency SCIDS in the first year of life;Manson;Pediatr. Radiol.,2013

4. Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency;Grunebaum;J. Allergy Clin. Immunol.,2012

5. Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency;Booth;J. Clin. Immunol.,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID;Nature Communications;2024-04-30

2. Disseminated mycobacterium genavense infection with central nervous system involvement in an HIV patient: a case report and literature review;BMC Infectious Diseases;2024-04-24

3. Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open‐label, single‐arm, phase 3, and postmarketing clinical study;Immunity, Inflammation and Disease;2023-07

4. Updated Management Guidelines for Adenosine Deaminase Deficiency;The Journal of Allergy and Clinical Immunology: In Practice;2023-06

5. Long-Term Immune Reconstitution in ADA-Deficient Patients Treated With Elapegademase: A Real-World Experience;The Journal of Allergy and Clinical Immunology: In Practice;2023-06